Article
Rapid clinical deployment of UBA1 testing in patients with VEXAS syndrome.
American journal of clinical pathology - 9 Sept 2025
Wadsworth Paul A, Chen Simon B, Lawrence Lauren, Ho Chandler C, Le Joseph E, Libiran Paolo, Grayson Peter C, Ferrada Marcela A, Beck David B, Suarez Carlos J
Abstract excerpt
OBJECTIVE: VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a recently described autoinflammatory syndrome caused by pathogenic variants in UBA1. However, there is a dearth of widely available UBA1 testing aside from large, expensive sequencing studies. Thus, we sought to rapidly develop, validate, and clinically deploy a cost-effective assay for detecting the most common UBA1 variants....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
